Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

L. Bakris, George; Fonseca, Vivian; E. Katholi, Richard; B. McGill, Janet; H. Messerli, Franz; A. Phillips, Robert; Raskin, Philip; T. Wright, Jackson; Oakes, Rosemary; Ann Lukas, Mary; M. Anderson, Karen; S.H. Bell, David; the GEMINI Investigators, for

doi:10.1001/jama.292.18.2227

Public

Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

Published in JAMA • Nov 9, 2004

Authors:

George L. Bakris

Vivian Fonseca

Richard E. Katholi

Abstract

CONTEXT: Beta-blockers have been shown to decrease cardiovascular risk in patients with hypertension and type 2 diabetes mellitus (DM); however, some components of the metabolic syndrome are worsened by some beta-blockers. OBJECTIVE: To compare the effects of beta-blockers with different pharmacolog...

Subject

Medicine

Carvedilol

Metoprolol

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!